Iterum Therapeutics Cash from Financing (TTM) Insights

Iterum Therapeutics PLC (ITRM)

1.44 -0.01 (-0.69%) USD | NASDAQ | Apr 17, 16:00

1.48 +0.04 (+2.78%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	1.034M
September 30, 2023	0.878M
June 30, 2023	0.868M
March 31, 2023	0.668M
December 31, 2022	-1.818M
September 30, 2022	-3.88M
June 30, 2022	-5.514M
March 31, 2022	-6.106M
December 31, 2021	83.13M
September 30, 2021	99.88M
June 30, 2021	102.28M
March 31, 2021	105.59M
December 31, 2020	64.48M

Date	Value
September 30, 2020	48.31M
June 30, 2020	50.58M
March 31, 2020	47.88M
December 31, 2019	2.063M
September 30, 2019	4.466M
June 30, 2019	1.428M
March 31, 2019	90.08M
December 31, 2018	122.20M
September 30, 2018	120.84M
June 30, 2018	120.84M
March 31, 2018	78.04M
December 31, 2017	45.87M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.106M

Minimum

Mar 2022

105.59M

Maximum

Mar 2021

31.38M

Average

2.063M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks